CNFN

Across TCGA pan-cancer cohorts, CNFN Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated CNFN data layer compared with 22 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher CNFN Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CNFN expression acts as an unfavorable survival marker.

KIRP, COAD, and LUSC are the cancer types where CNFN Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Median	All	0.132	0.904	<.001	36	view →
COAD	OS	Median	All	0.001	0.871	<.001	24	view →
LUSC	DFS	Median	II,III,IV	0.199	0.748	.006	12	view →
LIHC	OS	Median	All	0.144	0.688	.013	9	view →
SKCM	DFS	Median	All	0.023	0.738	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CNFN–KIRP (OS)

Open the KIRP breakdown →